Split-mouth randomized controlled trial comparing inflammatory biomarkers in early healing time of implant placement between Titanium and PEEK healing abutment

Faculty of Dentistry, Mahidol University0 个研究点目标入组 15 人开始时间: 2023年11月2日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Patient aged more than 20 years old.
•2.Patient with healthy condition who can undergo oral surgical procedure; ASA Class I or II.
•3.Patient whose presence of 1 Left and 1 right posterior edentulous sites in the same jaw (maxilla or mandible) which are planned to replace with 1 dental implant per site.
•4.The width, height, and interocclusal space of both edentulous sites are appropriate for inserting healing abutment size diameter 4.0, Height = 5.0-6.0 mm.
•5.Teeth at experimental sites were extracted at least 3 months earlier.
•6.The bone quantity and quality are adequate at the experimental sites that allow the placement of dental implants.
•7.The amount of keratinized gingiva buccolingually is at least 2 mm at the experimental sites.

•1.Smoking not less than 10 cigarettes/day (within past 12 months)
•2.Poorly controlled diabetes (HbA1c more than 8)
•3.Pregnancy
•4.Current use of medications that adversely affect healing (e.g., corticosteroids, chemotherapeutic, immunosuppressant drugs)
•5.History of head and neck radiation
•6.History of oral or IV bisphosphonate use
•7.Psychological, drug, or alcohol abuse patient
•8.History of drug allergy to one or more of drugs are as follows: Amoxicillin, Clindamycin, Ibuprofen, Paracetamol, and Chlorhexidine gluconate mouthwash

发起方

Faculty of Dentistry, Mahidol University